companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Amplify Therapeutics ApS

CVR: 43803999

Micro companyEstablished (3 yrs)Loss-making
Active
Own this company?

About Amplify Therapeutics ApS

Amplify Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Thomas Kirkegaard Jensen. The company is owned by Alpha Healthcare Investments ApS, Dare to Dream ApS and WoB Holding ApS. In 2025, the company reported a gross profit of DKK 925,944 and a net result of DKK -3,335,844 compared with DKK -7,194,854 the year before. Equity amounted to DKK -12,443,417.

Your company? Claim the profile and show your logo, website and social channels — for free.

Claim this profile

Overview

Company type
APS
Anpartsselskab
Address
Ole Maaløes Vej 3, 2200 København N
KØBENHAVN
2200 København N
Find nearby companies
Founded
23.1.2023

Details

Industry
Fremstilling af farmaceutiske præparater
Code: 212000
Secondary industries
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Capital
40.000 kr.

Contact

Advertising protected

Purpose

Selskabets formål er forskning, udvikling og kommercialisering af lægemidler

Location

Google Maps|Apple Maps|OpenStreetMap

Financials

YearGross ProfitProfit/LossTotal AssetsEquityEmployeesReport
2025926 t.-3.3 mio.3.4 mio.-12.4 mio.5
2024-5 mio.-7.2 mio.5.9 mio.-9.1 mio.3
2023-1.6 mio.-2 mio.2.6 mio.-1.9 mio.1

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Industry Benchmarks

View industry report

Compared to 129 companies in Fremstilling af farmaceutiske præparater

Employees
Company5
Industry median12
2.4x below
Equity ratio
Company-370.0%
Industry median62.0%
100% below

Comparison is based on industry median values

Ownership

Owners
Alpha Healthcare Investments ApS
CVR: 36508000
25-33,32%
Dare to Dream ApS
CVR: 38973452
33,33-49,99%
WoB Holding ApS
CVR: 38973525
25-33,32%
Amplify Therapeutics ApS
CVR: 43803999

Management

Directors

Thomas Kirkegaard Jensen(DIREKTØR)

Board

Anders Mørkeberg Hinsby(FORMAND)
Anders Vadsholt(BESTYRELSESMEDLEM)
Thomas Kirkegaard Jensen(BESTYRELSESMEDLEM)

PEP screening

Screen owners and management against the Danish FSA's official PEP lists

Founders

Alpha Healthcare Investments ApS
Dare to Dream ApS
WoB Holding ApS

Production units (1)

Amplify Therapeutics ApS
P-no: 1028962548
Ole Maaløes Vej 3, 2200, København N
Fremstilling af farmaceutiske præparater

Is this your company?

Free

Claim this page to add your logo and social links. Free to get started.

  • Verified badge on your profile
  • Upload your logo
  • Links to your website and social channels

History

12 events
2026
Amplify Therapeutics ApS: The 2025 annual report is outMar 10, 2026

Amplify Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK 925,944, and the net result was DKK -3,335,844.

2025
Amplify Therapeutics ApS: The 2024 annual report is outFeb 11, 2025

Amplify Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,961,503, and the net result was DKK -7,194,854.

2024
Amplify Therapeutics ApS: The 2023 annual report is outMar 18, 2024

Amplify Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -1,558,702, and the net result was DKK -1,952,719.

2023
Amplify Therapeutics ApS appoints new auditorJan 23, 2023

As of January 23, 2023, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Amplify Therapeutics ApS.

Anders Vadsholt joins the board of Amplify Therapeutics ApSJan 23, 2023

As of January 23, 2023, Anders Vadsholt has joined the board of directors of Amplify Therapeutics ApS.

Thomas Kirkegaard Jensen joins the board of Amplify Therapeutics ApSJan 23, 2023

As of January 23, 2023, Thomas Kirkegaard Jensen has joined the board of directors of Amplify Therapeutics ApS.

Anders Mørkeberg Hinsby joins the board of Amplify Therapeutics ApSJan 23, 2023

As of January 23, 2023, Anders Mørkeberg Hinsby has joined the board of directors of Amplify Therapeutics ApS.

Thomas Kirkegaard Jensen joins Amplify Therapeutics ApS as directorJan 23, 2023

As of January 23, 2023, Thomas Kirkegaard Jensen is registered as director of Amplify Therapeutics ApS.

Alpha Healthcare Investments ApS registered as owner of Amplify Therapeutics ApSJan 23, 2023

As of January 23, 2023, Alpha Healthcare Investments ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 25%.

Dare to Dream ApS registered as owner of Amplify Therapeutics ApSJan 23, 2023

As of January 23, 2023, Dare to Dream ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 33%.

WoB Holding ApS registered as owner of Amplify Therapeutics ApSJan 23, 2023

As of January 23, 2023, WoB Holding ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 25%.

Amplify Therapeutics ApS is foundedJan 23, 2023

Amplify Therapeutics ApS was founded on January 23, 2023.

Similar companies

Companies in the same industry and area

Antag Therapeutics ApS

CVR 38402056

Fremstilling af farmaceutiske præparater266 mKØBENHAVN5-9 employees

Cymab ApS

CVR 39859173

Fremstilling af farmaceutiske præparater266 mKØBENHAVN

Beo Therapeutics ApS

CVR 39880377

Fremstilling af farmaceutiske præparater266 mKØBENHAVN

Zyneyro ApS

CVR 42057428

Fremstilling af farmaceutiske præparater266 mKØBENHAVN

FimmCyte ApS

CVR 43432583

Fremstilling af farmaceutiske præparater266 mKØBENHAVN